← Leaderboards
Juan Fortea
University Of California-Irvine
$3,495,596
Attributed
$9,986,960
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,986,960 · 3
By mechanism
RF1$7,819,835 · 2
R01$2,167,125 · 1
Top collaborators
- Jorge A Busciglio6 shared
- A Claudio Cuello5 shared
- Thomas M Wisniewski5 shared
- Esther Marian Blessing1 shared
Most similar at University Of California-Irvine
Same institution · by research overlap
- Maria Corrada$27,878,582
- Michael A Yassa$21,614,052
- Mathew Mark Blurton-Jones$14,315,430
- Daniel L Gillen$13,101,745
- Wayne W Poon$7,008,264
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposS DiseaseFunctional DisorderImpaired CognitionBrainPlasmaCohortBiological MarkersStudy ModelsAlzheimerâS Disease BiomarkerMetabolic DysfunctionEvolutionBody FluidsMetabolismInflammationBiochemicalIn VitroBiologicalAffectAutopsyBasal ForebrainAdultGenetic ModelsDown Syndrome
Grant awards (7)
The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome$802,150
R01 · FY2025 · AG
The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome$259,200
R01 · FY2025 · AG
The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome$1,105,775
R01 · FY2024 · AG
Sleep and Temperature Disturbance as risk factors for Alzheimer's Disease in Down Syndrome: a Longitudinal Study$1,871,190
RF1 · FY2023 · AG
The Role of Inflammation and NGF Dysfunction in the Evolution of AlzheimerDisease Pathology in Down syndrome$563,692
RF1 · FY2020 · AG
The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down Syndrome-Revision$2,124,233
RF1 · FY2019 · AG
The Role of Inflammation and NGF Dysfunction in the Evolution of AlzheimerDisease Pathology in Down syndrome$3,260,720
RF1 · FY2018 · AG